What determines the cash price of the Zepbound KwikPen, including pharmacy and delivery fees?

The cash price of a Zepbound KwikPen is based on the manufacturer's list price, pharmacy fees, and eligibility for Lilly's Zepbound Savings Card program.

Zepbound's Manufacturer List Price

Eli Lilly and Company launched Zepbound with a list price of $1,059.87 for a one-month supply, which includes four pre-filled KwikPens. This price is the Wholesale Acquisition Cost (WAC) and does not include any pharmacy markups, dispensing fees, or other charges.

The list price is the starting point that the manufacturer sets before any negotiations, rebates, or discounts are applied. It is the price wholesalers pay to acquire the drug from the manufacturer.

It is important to note that very few patients, whether they have insurance or are paying with cash, will pay the full list price. The final cost is determined by a combination of factors, including pharmacy pricing and available savings programs.

Pharmacy Markups and Dispensing Fees

Retail pharmacies, whether they are large chains or small independents, purchase medications from wholesalers and add a markup to the price. This markup covers their operational costs, such as staffing and overhead, and includes their profit margin. Markups can vary significantly from one pharmacy to another.

In addition to a markup, most pharmacies charge a dispensing fee. This is a flat fee for the professional service of filling the prescription, verifying its accuracy, and counseling the patient. These fees are also variable and are sometimes regulated by state boards of pharmacy.

The combination of the pharmacy's acquisition cost, its percentage markup, and its flat dispensing fee results in the final cash price presented to a patient without insurance coverage or discounts. This is why the price for the same medication can differ between CVS, Walgreens, and an independent pharmacy.

The Zepbound Savings Card Program

To improve affordability, Eli Lilly offers a Zepbound Savings Card. This is the most significant factor in reducing the cash price for eligible patients. Eligibility is primarily restricted to patients with commercial drug insurance.

For patients with commercial insurance that covers Zepbound, the savings card can reduce the out-of-pocket cost to as little as $25 for a 1-month or 3-month prescription. This is the most affordable scenario.

For patients who have commercial insurance but it does not cover Zepbound, the savings card can still provide a substantial discount, lowering the cost of a 1-month prescription to as low as $550. This is a common option for patients whose plans exclude weight-loss medications.

Crucially, patients who are enrolled in any government-funded healthcare program, such as Medicare, Medicaid, or TRICARE, are not eligible to use the Zepbound Savings Card. These patients would face a cost closer to the pharmacy's cash price.

How Telehealth Programs Help Navigate Costs

Physician-supervised telehealth practices can assist patients in navigating the complex process of obtaining brand-name medications like Zepbound. These services go beyond just issuing a prescription.

A comprehensive [weight-loss](/weight-loss) program often includes benefits navigation, where the clinical team helps determine your insurance coverage, manages prior authorization paperwork, and directs you to pharmacies that can correctly process any available savings programs.

For patients paying cash, a telehealth platform can provide clarity on the expected price by working with partner pharmacies and ensuring all eligible discounts, like the Zepbound Savings Card, are applied, streamlining the entire process from consultation to medication delivery.

The Role of Pharmacy Benefit Managers (PBMs)

The high list price of drugs like Zepbound is influenced by an intermediary in the U.S. drug supply chain: the Pharmacy Benefit Manager (PBM). PBMs are third-party companies that manage prescription drug benefits on behalf of health insurance plans.

PBMs negotiate with drug manufacturers to secure large, confidential rebates in exchange for placing a drug on their plan's formulary (list of covered drugs). The high list price serves as a starting point for these rebate negotiations.

While these rebates lower the cost for the insurance plan, they are generally not passed directly to patients, especially those paying cash. This system contributes to a lack of price transparency and can leave uninsured patients facing the highest costs without assistance from savings programs.

Bottom Line

The cash price of a Zepbound KwikPen is not a single, fixed number. It begins with the manufacturer's list price of approximately $1,060 and is then adjusted by the specific pharmacy's markup and fees.

The most critical factor for reducing this cost is the Zepbound Savings Card. Eligible patients with commercial insurance can lower their monthly cost to around $550 if their plan doesn't cover the drug, or as low as $25 if it does.

Patients without commercial insurance (e.g., those on Medicare or the uninsured) are not eligible for the manufacturer's savings program and will face a price set by the pharmacy, which will be significantly higher.

This article is for informational purposes only and does not constitute medical advice.

Generated from GOAL.MD's physician-reviewed source library. This page has not received its own physician review. Physician-supervised telehealth. More at goal.md/answers.